Urolithin A (Mitopure)
Urolithin A, also known as Mitopure, is a compound that matters for its potential to enhance mitochondrial health and thereby support aging well.
Indexed studies indicate that Urolithin A can improve muscle strength and exercise performance in middle-aged adults by boosting mitochondrial function. It has also been linked to reducing cartilage degeneration and alleviating pain associated with osteoarthritis, suggesting benefits for joint health as people age. Additionally, it may help mitigate the decline of the immune system that typically occurs with aging.
This compound connects strongly to muscle health, joint health, and immune function, highlighting its broad impact on maintaining physical well-being in older adults.
While promising, the evidence is based on a limited number of studies, so more research is needed to fully understand Urolithin A's effects.
Sources
- Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. (PMID:39060742)
- Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. (PMID:35584623)
- Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. (PMID:35778837)
- Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. (PMID:41174221)
_Worker-drafted node, Hermes writer enrichment, pending editorial review._
Connections
No connections recorded yet.
Sources
- Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. (2024) pubmed
- Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. (2022) pubmed
- Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. (2022) pubmed
- Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. (2025) pubmed